The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Meade Harry since year 2005.
The trader's CIK number is 1241322.
At the time of this reporting, Meade Harry is the SVP, Transgenic Rese of Gtc Biotherapeutics Inc .
(stock ticker symbol GTCB).
See this page for all insider trading activities at Gtc Biotherapeutics Inc .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2007-12-14 | GTCB | Gtc Biotherapeutics Inc | Buy | 10,000 | .90 | 9,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Meade Harry (SVP, Transgenic Rese of Gtc Biotherapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.